1 min
xorlab Raises €5M to Scale Sovereign Email Security Across Europe
xorlab raised €5M to expand its AI-powered sovereign email security platform across DACH, Benelux and the Nordics.
Latest articles
1 min
Credas and Finity Partner to Automate Payroll Identity Verification
Credas partners with Finity to automate identity and right-to-work checks, reducing admin time and improving compliance for 150,000+ workers monthly.
1 min
Jeremy Renner Partners with RapidSOS to Advance AI Emergency Response
Jeremy Renner partners with RapidSOS to support AI-powered emergency response, improving real-time data access for first responders globally.
1 min
Semble Launches CQC Companion to Simplify Healthcare Compliance
Semble launches CQC Companion to help private clinics manage compliance, reduce stress, and prepare for inspections with step-by-step guidance.
1 min
Finom and Porters Partner to Automate Fintech Compliance Operations
Finom partners with Porters to automate compliance workflows using AI, processing 7,000+ documents and reducing manual effort in regulated operations.
1 min
Synera Raises $40M to Scale Agentic AI in Industrial Engineering
Synera raises $40M Series B to expand its agentic AI platform that automates industrial engineering workflows and accelerates product development.
1 min
Bluefish Raises $43M to Scale Agentic Marketing for Enterprises
Bluefish raises $43M Series B to expand its agentic marketing platform helping enterprises manage and optimize brand presence across AI channels.
1 min
pH7 Technologies Raises $32M to Scale Critical Mineral Extraction
pH7 raises $32M Series B to scale electrochemical technology that recovers critical minerals from low-grade ores and waste, improving supply chains.
3 min
The Nature of DeFi Market Data and Its Impact on AI Models
AI in DeFi is limited by noisy, fragmented data; success depends on managing uncertainty, not model complexity.
1 min
DeepCyte Raises $1.5M to Advance AI Toxicology in Drug Development
DeepCyte raises $1.5M to launch AI tools that predict and explain drug toxicity at single-cell level, improving clinical outcomes and reducing failures.